Assessing the Utility of a Capillary-Adjusted Oral Glucose Tolerance Test for the Early Detection of Type 1 Diabetes in Childhood

OBJECTIVE: The oral glucose tolerance test (OGTT) is the gold standard for staging and monitoring type 1 diabetes (T1D), but it requires venous sampling in a health care setting, limiting its accessibility. We assessed the utility of a capillary-adjusted OGTT (cOGTT) method in children and young people (CYP). METHODS: Study 1-OGTT method comparison: CYP across the glycemic range underwent contemporaneous venous (vGluc) and capillary (cGluc) glucose sampling at 0-min, 60-min (subgroup), and 120-min after a standard oral glucose load. Agreement between vGluc and cGluc was assessed using Bland-Altman between 3.5 and 15 mmol/L. Glycemic status was assessed using established thresholds and acceptability by questionnaire. Study 2-At-home OGTT feasibility: CYP with early-stage T1D undertook home cOGTT testing (0, 120 min) and completed acceptability questionnaires. RESULTS: Study 1: Forty-five CYP participated (mean [SD] age 12.2 [3.2] years; range 5-17), with 20 undergoing additional 60-min sampling. cGluc and vGluc showed reasonable agreement across the glycemic range of 3.5-15 mmol/L, (bias, -0.22 mmol/L; 95% confidence interval [CI]: -0.51 to 0.07; 95% limits of agreement, -2.91 to 2.47 mmol/L). cGluc performed well at normoglycemia: 21/22 (95% sensitivity; 95% CI: 77%-100%), 14/17 (82% specificity; 57%-96%); and hyperglycemia: 9/10 (90% sensitivity; 55%-100%), 29/29 (100% specificity; 88%-100%); but less well for dysglycemia: 4/7 (57% sensitivity; 18%-90%), 30/32 (94% specificity; 79%-99%). In 76% (32/42), cOGTT was preferred for future testing. Study 2: 45 CYP participated (10.4 [3.1] years; range 4-17). In 91% (41/45), home cOGTT tests were completed successfully (3 device failures, 1 incomplete test). Home testing was acceptable in 98% (44 of 45). Two CYP were identified with stage 3 T1D with no evidence of DKA. CONCLUSIONS: The cOGTT method is feasible and acceptable compared with venous OGTT in CYP, with promising performance for detecting hyperglycemia, but further assessment is needed before it can be used for glycemic staging.

Authors

Institutions

Publication Details

Journal
Diabetes Technology & Therapeutics
Published
2026-11-13
DOI
https://doi.org/10.1177/15209156261504106
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Assessing the Utility of a Capillary-Adjusted Oral Glucose Tolerance Test for the Early Detection of Type 1 Diabetes in Childhood

Y.-F Liu, J Birks, C Dayan, R Swaby et al.
3 links
Diabetes Technology & Therapeutics
Diabetes Management and Research
article

Assessing the Utility of a Capillary-Adjusted Oral Glucose Tolerance Test for the Early Detection of Type 1 Diabetes in Childhood

Y.-F Liu, J Birks, C Dayan, R Swaby, R Williams, S Luzio, R Besser, J Townson, A Shetty, K Gillespie, R Willemsen, G Dunseath
article en

Abstract

OBJECTIVE: The oral glucose tolerance test (OGTT) is the gold standard for staging and monitoring type 1 diabetes (T1D), but it requires venous sampling in a health care setting, limiting its accessibility. We assessed the utility of a capillary-adjusted OGTT (cOGTT) method in children and young people (CYP). METHODS: Study 1-OGTT method comparison: CYP across the glycemic range underwent contemporaneous venous (vGluc) and capillary (cGluc) glucose sampling at 0-min, 60-min (subgroup), and 120-min after a standard oral glucose load. Agreement between vGluc and cGluc was assessed using Bland-Altman between 3.5 and 15 mmol/L. Glycemic status was assessed using established thresholds and acceptability by questionnaire. Study 2-At-home OGTT feasibility: CYP with early-stage T1D undertook home cOGTT testing (0, 120 min) and completed acceptability questionnaires. RESULTS: Study 1: Forty-five CYP participated (mean [SD] age 12.2 [3.2] years; range 5-17), with 20 undergoing additional 60-min sampling. cGluc and vGluc showed reasonable agreement across the glycemic range of 3.5-15 mmol/L, (bias, -0.22 mmol/L; 95% confidence interval [CI]: -0.51 to 0.07; 95% limits of agreement, -2.91 to 2.47 mmol/L). cGluc performed well at normoglycemia: 21/22 (95% sensitivity; 95% CI: 77%-100%), 14/17 (82% specificity; 57%-96%); and hyperglycemia: 9/10 (90% sensitivity; 55%-100%), 29/29 (100% specificity; 88%-100%); but less well for dysglycemia: 4/7 (57% sensitivity; 18%-90%), 30/32 (94% specificity; 79%-99%). In 76% (32/42), cOGTT was preferred for future testing. Study 2: 45 CYP participated (10.4 [3.1] years; range 4-17). In 91% (41/45), home cOGTT tests were completed successfully (3 device failures, 1 incomplete test). Home testing was acceptable in 98% (44 of 45). Two CYP were identified with stage 3 T1D with no evidence of DKA. CONCLUSIONS: The cOGTT method is feasible and acceptable compared with venous OGTT in CYP, with promising performance for detecting hyperglycemia, but further assessment is needed before it can be used for glycemic staging.

Diabetes Technology & Therapeutics
Cardiff and Vale University Health Board (GB), Nottingham University Hospitals NHS Trust (GB), Centre for Human Genetics (GB), King's College London (GB), Guy's and St Thomas' NHS Foundation Trust (GB), Barts Health NHS Trust (GB), Royal London Hospital (GB), University of Bristol (GB), Swansea University (GB), University of Oxford (GB), NIHR Oxford Musculoskeletal Biomedical Research Centre (GB), Kings Health Partners (GB), Noah's Ark Children's Hospital for Wales (GB), Cardiff University (GB)
UK Research and Innovation, National Institute for Health and Care Research, University of Bristol, Novo Nordisk
Good health and well-being
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon